OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-based design and synthesis of sulfonylureas as novel NLRP3 inhibitors for Alzheimer’s disease
Eun Young Kim, Jae Hong Im, Jinhe Han, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129622-129622
Closed Access | Times Cited: 5
Eun Young Kim, Jae Hong Im, Jinhe Han, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129622-129622
Closed Access | Times Cited: 5
Showing 5 citing articles:
Donepezil-Based Rational Design of N-Substituted Quinazolinthioacetamide Candidates as Potential Acetylcholine Esterase Inhibitors for the Treatment of Alzheimer’s Disease: In vitro and In vivo Studies
Ahmed A. Al‐Karmalawy, Ahmed F. Mohamed, Heba Nasr Shalaby, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Ahmed A. Al‐Karmalawy, Ahmed F. Mohamed, Heba Nasr Shalaby, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Inflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer’s Disease Pathogenesis
Jacqueline A. McGroarty, Shelbi Salinas, Helen Evans, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 676-676
Open Access
Jacqueline A. McGroarty, Shelbi Salinas, Helen Evans, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 676-676
Open Access
Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
Tanvir Ahmed, Junghyun Jo, Sang Myun Park
Cells (2024) Vol. 13, Iss. 22, pp. 1876-1876
Open Access | Times Cited: 3
Tanvir Ahmed, Junghyun Jo, Sang Myun Park
Cells (2024) Vol. 13, Iss. 22, pp. 1876-1876
Open Access | Times Cited: 3
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors
Baljit Kaur, Savannah Biby, Jannatun Nayem Namme, et al.
Advances in pharmacology (2024), pp. 103-157
Closed Access
Baljit Kaur, Savannah Biby, Jannatun Nayem Namme, et al.
Advances in pharmacology (2024), pp. 103-157
Closed Access
Advances in Developing Small Molecule Drugs for Alzheimer's Disease
Wei Zhang, Liujie Zhang, Mingti Lv, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 4, pp. 221-231
Closed Access
Wei Zhang, Liujie Zhang, Mingti Lv, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 4, pp. 221-231
Closed Access
